DiaMedica Therapeutics DMAC
NASDAQ DMAC
$8.35 +0.08 (+0.97%)
At close: Oct 1, 2026 · 4:00 PM EDT

DiaMedica Therapeutics (DMAC) Return on Assets [ROA] (2019 - 2026)

Updated

DiaMedica Therapeutics (DMAC) posted Return on Assets [ROA] of -76.55% for Q2 2026, up 7.60 percentage points from -84.15% a year earlier but down 15.21 percentage points from the prior quarter.

Analysis

DiaMedica Therapeutics (DMAC) Return on Assets [ROA] (2019 - 2026) Analysis & Trends

For FY2025, DiaMedica Therapeutics' Return on Assets [ROA] came in at -60.84%, down 12.20 percentage points from FY2024.

  • Annual Return on Assets [ROA] has declined for three consecutive years, though with a five-year change of +5.34 percentage points (FY2020 to FY2025).
  • In prior years, DiaMedica Therapeutics' Return on Assets [ROA] was -48.64% in FY2024 (-4.87 pp), -43.77% in FY2023 (-9.56 pp), -34.21% in FY2022 (+2.70 pp) and -36.91% in FY2021 (+29.27 pp).
  • Quarterly Return on Assets [ROA] has run from a low of -84.15% in Q2 2025 to a high of -28.85% in Q4 2021 over five years.
  • On a year-over-year basis, Return on Assets [ROA] increased in two of the last eight quarters, with an average year-over-year change of -15.77 percentage points.
  • The strongest year-over-year quarter for Return on Assets [ROA] in the past five years was Q2 2022, with a gain of 28.66 percentage points; the weakest was Q2 2025, with a drop of 46.62 percentage points.
  • According to Business Quant data, Return on Assets [ROA] for the three prior quarters was -61.34% (Q1 2026), -55.34% (Q4 2025) and -72.14% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 10.47%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 4.65%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.45%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 28.37%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 9.10%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 9.29%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -6.13%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 2.14%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 16.34%
10 DiaMedica Therapeutics 445.97 Mn 445.97 Mn - -76.55%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -76.55%
Mar 31, 2026 -61.34%
Dec 31, 2025 -55.34%
Sep 30, 2025 -72.14%
Jun 30, 2025 -84.15%
Mar 31, 2025 -63.40%
Dec 31, 2024 -49.45%
Sep 30, 2024 -39.71%
Jun 30, 2024 -37.53%
Mar 31, 2024 -37.25%
Dec 31, 2023 -34.52%
Sep 30, 2023 -29.90%
Jun 30, 2023 -35.89%
Mar 31, 2023 -47.79%
Dec 31, 2022 -38.29%
Sep 30, 2022 -34.52%
Jun 30, 2022 -33.29%
Mar 31, 2022 -30.71%
Dec 31, 2021 -28.85%
Sep 30, 2021 -41.30%
API Access

DiaMedica Therapeutics Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=DMAC&period=max&api_key=YOUR_API_KEY